With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...

Spread the loveIf you’re a developer working with GitHub, you’re probably familiar with the web interface. It’s great for ...

South Africa's top court blocks Shell's Wild Coast exploration plans South Africa's Constitutional Court on Friday blocked offshore exploration led by Shell along the country's ‌pristine Wild Coast, a ...